Title : Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID-19 - Manickam_2021_Arch.Pharm.(Weinheim)__e2100367 |
Author(s) : Manickam M , Meenakshisundaram S , Pillaiyar T |
Ref : Arch Pharm (Weinheim) , :e2100367 , 2021 |
Abstract : |
PubMedSearch : Manickam_2021_Arch.Pharm.(Weinheim)__e2100367 |
PubMedID: 34802171 |
Title : Discovery of enantioselectivity of urea inhibitors of soluble epoxide hydrolase - Manickam_2016_Eur.J.Med.Chem_117_113 |
Author(s) : Manickam M , Pillaiyar T , Boggu P , Venkateswararao E , Jalani HB , Kim ND , Lee SK , Jeon JS , Kim SK , Jung SH |
Ref : Eur Journal of Medicinal Chemistry , 117 :113 , 2016 |
Abstract : |
PubMedSearch : Manickam_2016_Eur.J.Med.Chem_117_113 |
PubMedID: 27092411 |
Gene_locus related to this paper: human-EPHX2 |